CIK 0001661053 · Non-accelerated filer<br>Smaller reporting company
enVVeno Medical Corp
Sign in to watch- Ticker
- NVNO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330936180
- Phone
- 949-261-2900
- Business address
- 70 DOPPLER, IRVINE, CA, 92618
- Former names
- Hancock Jaffe Laboratories, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $123
- in 1 filing, $123 under 10b5-1 plans
Net −$123. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-16 | BERMAN ROBERT ANDREW CEO | Purchase | +2,000 | $7.87 | $16K | 5,736 |
| 2021-09-13 | Jenusaitis Matthew Director | Option exercise | +1,042 | 5,884 | ||
| 2021-09-13 | Jenusaitis Matthew Director | Option exercise · Restricted Stock Units | −1,042 | 2,084 | ||
| 2021-09-13 | Gray Robert Director | Option exercise | +1,042 | 6,614 | ||
| 2021-09-13 | Gray Robert Director | Option exercise · Restricted Stock Units | −1,042 | 2,084 | ||
| 2021-08-25 | Jenusaitis Matthew Director | Purchase | +1,300 | $7.70 | $10K | 4,842 |
| 2021-06-16 | Gray Robert Director | Purchase | +2,000 | $6.25 | $13K | 5,572 |
| 2021-05-21 | Glickman Marc H. SVP & Chief Medical Officer | Purchase | +1,600 | $5.90 | $9K | 1,600 |
| 2021-05-18 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +3,000 | $5.47 | $16K | 3,736 |
| 2021-05-17 | Duhay Francis Director | Purchase | +9,492 | $5.33 | $51K | 13,160 |
| 2021-02-18 | Glynn Craig Chief Financial Officer | Grant or award · Stock Option | +324,000 | 324 | ||
| 2021-02-18 | Duhay Francis Director | Grant or award · Stock Option | +5,673 | 5,673 | ||
| 2021-02-18 | Jenusaitis Matthew Director | Grant or award · Stock Option | +5,673 | 5,673 | ||
| 2021-02-18 | Shrivastava Sanjay Director | Grant or award · Stock Option | +5,673 | 5,673 | ||
| 2021-02-18 | BERMAN ROBERT ANDREW Chief Executive Officer | Grant or award · Stock Option | +838,000 | 838,000 | ||
| 2021-02-18 | Gray Robert Director | Grant or award · Stock Option | +5,673 | 5,673 | ||
| 2021-02-18 | Glickman Marc H. SVP & CMO | Grant or award · Stock Option | +406,000 | 406,000 | ||
| 2020-08-21 | Biodyne Holding, S.A. Former 10% Owner | Sale | −75,000 | $0.38 | $29K | 1,405,433 |
| 2020-08-20 | Biodyne Holding, S.A. Former 10% Owner | Sale | −75,000 | $0.27 | $20K | 1,480,433 |
| 2020-08-19 | Biodyne Holding, S.A. Former 10% Owner | Sale | −50,000 | $0.30 | $15K | 1,555,433 |
Page 4 of 8 · 141 trades